Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2021-10-05 00:00:00 ET · period of report 2021-10-04 · accession 0001209191-21-059353 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-10-05 | 2021-10-04 | TVTX | Heerma Peter | Chief Commercial Off | S - Sale | $24.77 | -3,058 | 60.5K | -5% | -$75.7K |
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-04 | S | D | 3,058 | $24.77 | 60,457 | D | — | — |